Smoking Cessation Smartphone App for Cancer Patients (Quit2Heal Study)

NCT ID: NCT03600038

Last Updated: 2019-12-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

59 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-04-02

Study Completion Date

2019-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to determine whether the novel smartphone application designed specifically for cancer patients to quit smoking (Quit2Heal) provides higher quit rates than the current standard smoking cessation app.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cigarette smoking has harmful effects on cancer patients' treatment and prognosis, but there are systemic barriers to delivering smoking cessation interventions to cancer patients. One solution for addressing these barriers is to give patients immediate access to smoking cessation treatment via a smartphone application. The Quit2Heal smartphone app is engaging and tailored to the specific needs of cancer patients, and can be integrated into routine cancer care. The goal of this study is to determine whether Quit2Heal provides higher quit rates than the current standard smoking cessation app.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Smoking

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Smoking cessation App for quitting smoking Cancer Oncology

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental

This is the experimental arm of the study. This includes receiving the novel/experimental smoking cessation smartphone app. Therapy description of experimental app withheld to protect the integrity of the study.

Group Type EXPERIMENTAL

Experimental smoking cessation smartphone app

Intervention Type BEHAVIORAL

The experimental arm includes an intervention using a novel/experimental smartphone smoking cessation app.

Control

This is the control arm of the study. This includes receiving the standard of care smoking cessation smartphone app. Therapy description of standard of care app withheld to protect the integrity of the study.

Group Type ACTIVE_COMPARATOR

Standard of care smoking cessation smartphone app

Intervention Type BEHAVIORAL

The control intervention uses a standard of care smartphone smoking cessation app.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Experimental smoking cessation smartphone app

The experimental arm includes an intervention using a novel/experimental smartphone smoking cessation app.

Intervention Type BEHAVIORAL

Standard of care smoking cessation smartphone app

The control intervention uses a standard of care smartphone smoking cessation app.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 18 or older
* diagnosed with cancer in the past 12 months
* has smoked a cigarette (even a puff) in the past 30 days
* interested in learning skills to quit smoking
* willing to be randomly assigned to either smartphone application
* resides in US
* has at least daily access to their own smartphone
* knows how to login and download a smartphone application from the Apple app store or Android Play app store
* willing and able to read in English
* not currently using cessation medications or enrolled in other smoking cessation programs, and
* has never used the NCI's Quit Guide smartphone application.
* willing and able to complete one follow-up survey
* willing to provide email, phone, and mailing address.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

CVS Health Foundation

UNKNOWN

Sponsor Role collaborator

Fred Hutchinson Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jonathan Bricker

Role: PRINCIPAL_INVESTIGATOR

Fred Hutch/University of Washington Cancer Consortium

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fred Hutchinson Cancer Research Center

Seattle, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Bricker JB, Watson NL, Heffner JL, Sullivan B, Mull K, Kwon D, Westmaas JL, Ostroff J. A Smartphone App Designed to Help Cancer Patients Stop Smoking: Results From a Pilot Randomized Trial on Feasibility, Acceptability, and Effectiveness. JMIR Form Res. 2020 Jan 17;4(1):e16652. doi: 10.2196/16652.

Reference Type DERIVED
PMID: 31951215 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Related Links

Access external resources that provide additional context or updates about the study.

http://www.quit2heal.org

Quit2Heal Study recruitment website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NCI-2018-02641

Identifier Type: REGISTRY

Identifier Source: secondary_id

RG1001682

Identifier Type: OTHER

Identifier Source: secondary_id

P30CA015704

Identifier Type: NIH

Identifier Source: secondary_id

View Link

8630

Identifier Type: -

Identifier Source: org_study_id